Does SIPONIMOD Cause Multiple sclerosis relapse? 504 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 504 reports of Multiple sclerosis relapse have been filed in association with SIPONIMOD (MAYZENT). This represents 5.9% of all adverse event reports for SIPONIMOD.
504
Reports of Multiple sclerosis relapse with SIPONIMOD
5.9%
of all SIPONIMOD reports
4
Deaths
132
Hospitalizations
How Dangerous Is Multiple sclerosis relapse From SIPONIMOD?
Of the 504 reports, 4 (0.8%) resulted in death, 132 (26.2%) required hospitalization, and 4 (0.8%) were considered life-threatening.
Is Multiple sclerosis relapse Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIPONIMOD. However, 504 reports have been filed with the FAERS database.
What Other Side Effects Does SIPONIMOD Cause?
Fatigue (958)
Headache (862)
Dizziness (654)
Gait disturbance (506)
Fall (478)
Multiple sclerosis (455)
Lymphocyte count decreased (398)
Nausea (397)
Drug ineffective (396)
Product dose omission issue (381)
What Other Drugs Cause Multiple sclerosis relapse?
DIMETHYL (6,852)
FINGOLIMOD (6,728)
NATALIZUMAB (6,478)
INTERFERON BETA-1A (5,931)
TERIFLUNOMIDE (4,745)
GLATIRAMER (3,695)
DALFAMPRIDINE (3,322)
OCRELIZUMAB (2,326)
OFATUMUMAB (1,525)
INTERFERON BETA-1B (1,229)
Which SIPONIMOD Alternatives Have Lower Multiple sclerosis relapse Risk?
SIPONIMOD vs SIPULEUCEL-T
SIPONIMOD vs SIROLIMUS
SIPONIMOD vs SIRUKUMAB
SIPONIMOD vs SITAGLIPTIN
SIPONIMOD vs SKYLA